| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Pharmacy | 12 | 2024 | 81 | 4.710 |
Why?
|
| Education, Pharmacy | 11 | 2024 | 61 | 4.390 |
Why?
|
| Nonprescription Drugs | 19 | 2018 | 54 | 4.350 |
Why?
|
| Drug Labeling | 12 | 2018 | 29 | 3.350 |
Why?
|
| Health Expenditures | 7 | 2025 | 134 | 3.040 |
Why?
|
| Prescription Drugs | 7 | 2023 | 52 | 2.030 |
Why?
|
| Healthcare Disparities | 4 | 2025 | 506 | 1.860 |
Why?
|
| United States | 37 | 2025 | 11800 | 1.320 |
Why?
|
| Cross-Sectional Studies | 27 | 2025 | 3834 | 1.290 |
Why?
|
| Pharmacists | 13 | 2013 | 103 | 1.270 |
Why?
|
| Students | 4 | 2021 | 251 | 1.240 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 501 | 1.180 |
Why?
|
| Educational Measurement | 6 | 2024 | 317 | 1.090 |
Why?
|
| Cardiovascular Diseases | 3 | 2025 | 2082 | 1.080 |
Why?
|
| Medicare Part C | 2 | 2016 | 35 | 0.960 |
Why?
|
| Adult | 42 | 2025 | 31702 | 0.950 |
Why?
|
| School Admission Criteria | 3 | 2023 | 29 | 0.920 |
Why?
|
| Arthritis | 1 | 2025 | 85 | 0.890 |
Why?
|
| Health Services Accessibility | 3 | 2025 | 696 | 0.890 |
Why?
|
| Surveys and Questionnaires | 18 | 2024 | 4039 | 0.860 |
Why?
|
| Curriculum | 3 | 2024 | 783 | 0.860 |
Why?
|
| Schools, Pharmacy | 5 | 2024 | 26 | 0.830 |
Why?
|
| Life Change Events | 2 | 2023 | 63 | 0.820 |
Why?
|
| Humans | 83 | 2025 | 131604 | 0.810 |
Why?
|
| Chiropractic | 1 | 2023 | 2 | 0.800 |
Why?
|
| Manipulation, Chiropractic | 1 | 2023 | 2 | 0.800 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2015 | 76 | 0.790 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2016 | 267 | 0.780 |
Why?
|
| Acetaminophen | 2 | 2015 | 97 | 0.770 |
Why?
|
| Medicare Part D | 2 | 2020 | 12 | 0.770 |
Why?
|
| Female | 51 | 2025 | 71145 | 0.770 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 651 | 0.740 |
Why?
|
| Aged | 27 | 2025 | 21255 | 0.740 |
Why?
|
| Male | 48 | 2025 | 65228 | 0.740 |
Why?
|
| Perception | 6 | 2016 | 228 | 0.730 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1413 | 0.730 |
Why?
|
| Complementary Therapies | 2 | 2013 | 43 | 0.710 |
Why?
|
| Retrospective Studies | 17 | 2025 | 17666 | 0.710 |
Why?
|
| Texas | 19 | 2024 | 3615 | 0.700 |
Why?
|
| Health Status Disparities | 1 | 2024 | 278 | 0.690 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 256 | 0.690 |
Why?
|
| Health Status Indicators | 2 | 2014 | 124 | 0.670 |
Why?
|
| United States Food and Drug Administration | 9 | 2024 | 156 | 0.670 |
Why?
|
| Middle Aged | 32 | 2025 | 28883 | 0.660 |
Why?
|
| Self Medication | 5 | 2012 | 21 | 0.660 |
Why?
|
| Attitude of Health Personnel | 5 | 2016 | 714 | 0.660 |
Why?
|
| Diabetes Complications | 1 | 2022 | 199 | 0.660 |
Why?
|
| Health Status | 3 | 2024 | 387 | 0.650 |
Why?
|
| Health Behavior | 4 | 2017 | 390 | 0.650 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 327 | 0.640 |
Why?
|
| Pharmacy | 1 | 2020 | 18 | 0.640 |
Why?
|
| Medication Therapy Management | 2 | 2016 | 22 | 0.620 |
Why?
|
| Cognition | 4 | 2018 | 843 | 0.620 |
Why?
|
| Universities | 3 | 2018 | 122 | 0.590 |
Why?
|
| Intention | 4 | 2022 | 100 | 0.580 |
Why?
|
| Interviews as Topic | 2 | 2018 | 440 | 0.580 |
Why?
|
| Immunotherapy | 1 | 2024 | 765 | 0.570 |
Why?
|
| Psychological Theory | 3 | 2016 | 35 | 0.560 |
Why?
|
| Patient Compliance | 3 | 2015 | 469 | 0.560 |
Why?
|
| Quality of Life | 3 | 2015 | 2113 | 0.560 |
Why?
|
| Health Services | 1 | 2018 | 68 | 0.560 |
Why?
|
| Medication Adherence | 2 | 2023 | 334 | 0.540 |
Why?
|
| Consumer Behavior | 3 | 2004 | 31 | 0.540 |
Why?
|
| Academic Performance | 1 | 2017 | 25 | 0.540 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 463 | 0.530 |
Why?
|
| Pamphlets | 1 | 2017 | 23 | 0.530 |
Why?
|
| Ephedrine | 2 | 2008 | 5 | 0.530 |
Why?
|
| Reading | 1 | 2018 | 78 | 0.520 |
Why?
|
| Clinical Pharmacy Information Systems | 3 | 2006 | 19 | 0.500 |
Why?
|
| Socioeconomic Factors | 4 | 2025 | 897 | 0.500 |
Why?
|
| Young Adult | 16 | 2024 | 10094 | 0.480 |
Why?
|
| Drug Information Services | 4 | 2004 | 5 | 0.450 |
Why?
|
| Prescription Drug Overuse | 1 | 2015 | 4 | 0.450 |
Why?
|
| Medication Systems, Hospital | 4 | 2011 | 37 | 0.440 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 418 | 0.440 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2015 | 142 | 0.440 |
Why?
|
| Learning | 1 | 2017 | 369 | 0.430 |
Why?
|
| Nursing Staff, Hospital | 2 | 2012 | 70 | 0.420 |
Why?
|
| Social Class | 1 | 2015 | 211 | 0.420 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 1542 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2024 | 902 | 0.410 |
Why?
|
| Formularies as Topic | 2 | 2004 | 2 | 0.410 |
Why?
|
| Mental Disorders | 1 | 2021 | 901 | 0.390 |
Why?
|
| Drug Monitoring | 1 | 2016 | 285 | 0.390 |
Why?
|
| Parenting | 1 | 2017 | 349 | 0.390 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 475 | 0.380 |
Why?
|
| Drugs, Generic | 4 | 2013 | 13 | 0.380 |
Why?
|
| Public Opinion | 1 | 2013 | 63 | 0.380 |
Why?
|
| Consumer Health Information | 1 | 2012 | 28 | 0.370 |
Why?
|
| Demography | 2 | 2023 | 243 | 0.370 |
Why?
|
| Achievement | 2 | 2015 | 32 | 0.370 |
Why?
|
| Communication | 1 | 2016 | 530 | 0.370 |
Why?
|
| Professional Role | 5 | 2013 | 76 | 0.360 |
Why?
|
| Stress, Psychological | 1 | 2017 | 562 | 0.360 |
Why?
|
| Efficiency | 1 | 2012 | 71 | 0.360 |
Why?
|
| Attitude to Health | 1 | 2013 | 251 | 0.350 |
Why?
|
| Exercise | 1 | 2017 | 866 | 0.350 |
Why?
|
| Body Mass Index | 1 | 2017 | 1695 | 0.350 |
Why?
|
| Chronic Disease | 1 | 2016 | 1234 | 0.350 |
Why?
|
| Behind-the-Counter Drugs | 1 | 2011 | 1 | 0.340 |
Why?
|
| Education, Pharmacy, Graduate | 2 | 2024 | 10 | 0.340 |
Why?
|
| Emigrants and Immigrants | 1 | 2013 | 169 | 0.330 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 610 | 0.330 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 117 | 0.330 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 174 | 0.320 |
Why?
|
| Drug and Narcotic Control | 3 | 2019 | 16 | 0.320 |
Why?
|
| Legislation, Drug | 2 | 2008 | 8 | 0.320 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2019 | 775 | 0.310 |
Why?
|
| Pharmaceutical Services | 2 | 2016 | 35 | 0.310 |
Why?
|
| Health Surveys | 2 | 2008 | 262 | 0.310 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2010 | 36 | 0.310 |
Why?
|
| Cost of Illness | 1 | 2011 | 291 | 0.310 |
Why?
|
| Hematinics | 1 | 2010 | 60 | 0.300 |
Why?
|
| Hospitalization | 1 | 2018 | 1939 | 0.300 |
Why?
|
| Cystic Fibrosis | 1 | 2011 | 267 | 0.290 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 890 | 0.290 |
Why?
|
| Physicians | 6 | 2019 | 634 | 0.290 |
Why?
|
| Pseudoephedrine | 1 | 2008 | 1 | 0.280 |
Why?
|
| Hydrocodone | 2 | 2019 | 36 | 0.270 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 6922 | 0.270 |
Why?
|
| Consumer Product Safety | 2 | 2004 | 29 | 0.270 |
Why?
|
| Pharmaceutical Preparations | 2 | 2005 | 81 | 0.270 |
Why?
|
| Drug Packaging | 2 | 2005 | 7 | 0.260 |
Why?
|
| Community Participation | 2 | 2012 | 43 | 0.260 |
Why?
|
| Cohort Studies | 3 | 2024 | 5123 | 0.250 |
Why?
|
| Cost-Benefit Analysis | 2 | 2010 | 543 | 0.250 |
Why?
|
| Lymphoma | 1 | 2010 | 330 | 0.250 |
Why?
|
| Drug Prescriptions | 3 | 2006 | 230 | 0.250 |
Why?
|
| Community Pharmacy Services | 4 | 2013 | 10 | 0.250 |
Why?
|
| Drug Industry | 2 | 2004 | 48 | 0.250 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2006 | 39 | 0.240 |
Why?
|
| Language | 1 | 2007 | 218 | 0.240 |
Why?
|
| Anemia | 1 | 2010 | 355 | 0.240 |
Why?
|
| Medicare | 2 | 2020 | 437 | 0.240 |
Why?
|
| Methamphetamine | 1 | 2006 | 50 | 0.230 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2012 | 8 | 0.230 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 129 | 0.230 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2005 | 23 | 0.220 |
Why?
|
| Doping in Sports | 1 | 2005 | 7 | 0.220 |
Why?
|
| Substance Abuse Detection | 1 | 2005 | 40 | 0.220 |
Why?
|
| Electronic Health Records | 1 | 2012 | 810 | 0.220 |
Why?
|
| Hair Follicle | 1 | 2005 | 33 | 0.220 |
Why?
|
| Adolescent | 13 | 2018 | 20931 | 0.220 |
Why?
|
| Motivation | 1 | 2006 | 334 | 0.210 |
Why?
|
| Computers | 1 | 2004 | 69 | 0.210 |
Why?
|
| Marijuana Abuse | 1 | 2024 | 53 | 0.210 |
Why?
|
| Drug Approval | 1 | 2024 | 45 | 0.210 |
Why?
|
| Histamine H1 Antagonists | 1 | 2003 | 13 | 0.210 |
Why?
|
| Blindness | 1 | 2004 | 72 | 0.200 |
Why?
|
| Societies, Pharmaceutical | 1 | 2003 | 14 | 0.200 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2003 | 21 | 0.200 |
Why?
|
| Neck Pain | 1 | 2023 | 20 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 168 | 0.200 |
Why?
|
| Job Satisfaction | 1 | 2004 | 99 | 0.200 |
Why?
|
| Back Pain | 1 | 2023 | 30 | 0.200 |
Why?
|
| Prescription Fees | 2 | 2013 | 3 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 470 | 0.200 |
Why?
|
| Heart Diseases | 1 | 2008 | 505 | 0.190 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 139 | 0.190 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 331 | 0.190 |
Why?
|
| Comprehension | 2 | 2017 | 76 | 0.190 |
Why?
|
| Pharmacies | 1 | 2022 | 15 | 0.190 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2648 | 0.190 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 260 | 0.190 |
Why?
|
| Community Health Centers | 2 | 2012 | 37 | 0.180 |
Why?
|
| Internet | 1 | 2005 | 419 | 0.180 |
Why?
|
| Risk | 2 | 2015 | 739 | 0.180 |
Why?
|
| Psychometrics | 2 | 2017 | 671 | 0.180 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 163 | 0.180 |
Why?
|
| Academic Success | 1 | 2021 | 22 | 0.170 |
Why?
|
| College Admission Test | 1 | 2020 | 7 | 0.160 |
Why?
|
| Controlled Substances | 2 | 2019 | 11 | 0.160 |
Why?
|
| HIV Infections | 3 | 2014 | 2037 | 0.160 |
Why?
|
| Computers, Handheld | 2 | 2010 | 33 | 0.150 |
Why?
|
| Acute Pain | 1 | 2019 | 18 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2003 | 557 | 0.150 |
Why?
|
| Databases, Factual | 3 | 2016 | 1224 | 0.150 |
Why?
|
| Insurance Coverage | 1 | 2020 | 117 | 0.150 |
Why?
|
| Health Care Surveys | 5 | 2019 | 282 | 0.140 |
Why?
|
| Anxiety | 2 | 2021 | 1003 | 0.140 |
Why?
|
| Data Collection | 4 | 2007 | 371 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2986 | 0.140 |
Why?
|
| Patient Participation | 2 | 2017 | 244 | 0.140 |
Why?
|
| Attitude | 2 | 2012 | 111 | 0.140 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1405 | 0.140 |
Why?
|
| Logistic Models | 3 | 2018 | 1831 | 0.140 |
Why?
|
| Vaccines | 1 | 2022 | 384 | 0.130 |
Why?
|
| Medication Errors | 3 | 2011 | 193 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2004 | 1099 | 0.130 |
Why?
|
| Chronic Pain | 1 | 2019 | 159 | 0.130 |
Why?
|
| Arabs | 1 | 2015 | 29 | 0.120 |
Why?
|
| Nursing Evaluation Research | 2 | 2012 | 9 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2011 | 955 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 459 | 0.110 |
Why?
|
| Tobacco Products | 1 | 2015 | 61 | 0.110 |
Why?
|
| Watchful Waiting | 1 | 2016 | 74 | 0.110 |
Why?
|
| Forecasting | 1 | 2016 | 361 | 0.110 |
Why?
|
| Parent-Child Relations | 1 | 2017 | 255 | 0.110 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2006 | 46 | 0.110 |
Why?
|
| Choice Behavior | 1 | 1996 | 132 | 0.110 |
Why?
|
| Mammography | 1 | 2015 | 131 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1405 | 0.110 |
Why?
|
| Age Factors | 3 | 2015 | 2872 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2016 | 3695 | 0.110 |
Why?
|
| Smoking Cessation | 1 | 2015 | 190 | 0.100 |
Why?
|
| Workflow | 2 | 2011 | 139 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2016 | 397 | 0.100 |
Why?
|
| Phytotherapy | 1 | 2013 | 46 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2015 | 366 | 0.090 |
Why?
|
| Diagnosis-Related Groups | 1 | 2012 | 28 | 0.090 |
Why?
|
| Medical Assistance | 1 | 2012 | 6 | 0.090 |
Why?
|
| Time Management | 2 | 2015 | 8 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 432 | 0.090 |
Why?
|
| Self Report | 1 | 2015 | 558 | 0.090 |
Why?
|
| Risk Factors | 2 | 2016 | 10959 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2022 | 15054 | 0.090 |
Why?
|
| Nurses | 1 | 2011 | 79 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2011 | 6494 | 0.080 |
Why?
|
| Educational Status | 2 | 2015 | 281 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 901 | 0.070 |
Why?
|
| Attitude to Computers | 2 | 2010 | 39 | 0.070 |
Why?
|
| Neoplasms | 1 | 2023 | 2969 | 0.070 |
Why?
|
| Health Policy | 1 | 2010 | 227 | 0.070 |
Why?
|
| Commerce | 1 | 2008 | 58 | 0.070 |
Why?
|
| Test Anxiety Scale | 1 | 2006 | 2 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 998 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 227 | 0.060 |
Why?
|
| Child | 3 | 2022 | 26250 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2016 | 1215 | 0.060 |
Why?
|
| Length of Stay | 1 | 2012 | 1399 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2010 | 1521 | 0.060 |
Why?
|
| Time and Motion Studies | 3 | 2011 | 17 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2006 | 322 | 0.060 |
Why?
|
| Models, Psychological | 2 | 2016 | 141 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2006 | 102 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1387 | 0.060 |
Why?
|
| Medical Order Entry Systems | 1 | 2006 | 108 | 0.060 |
Why?
|
| Poverty | 3 | 2013 | 455 | 0.050 |
Why?
|
| Placebos | 1 | 2005 | 227 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2004 | 26 | 0.050 |
Why?
|
| Social Behavior | 1 | 2006 | 217 | 0.050 |
Why?
|
| Human Genome Project | 1 | 2004 | 55 | 0.050 |
Why?
|
| Spain | 1 | 2004 | 62 | 0.050 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2003 | 3 | 0.050 |
Why?
|
| Diphenhydramine | 1 | 2003 | 12 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2004 | 56 | 0.050 |
Why?
|
| Hospital Information Systems | 1 | 2003 | 42 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 493 | 0.050 |
Why?
|
| Disease Progression | 1 | 2010 | 2206 | 0.050 |
Why?
|
| Home Care Services | 1 | 2003 | 69 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2004 | 203 | 0.050 |
Why?
|
| Algorithms | 1 | 2010 | 1686 | 0.050 |
Why?
|
| Bioethics | 1 | 2004 | 81 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 200 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2003 | 161 | 0.050 |
Why?
|
| Health Services Research | 1 | 2004 | 178 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2003 | 178 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1516 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2003 | 133 | 0.050 |
Why?
|
| Periodicals as Topic | 1 | 2004 | 180 | 0.040 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2003 | 144 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2002 | 236 | 0.040 |
Why?
|
| Faculty | 1 | 2021 | 95 | 0.040 |
Why?
|
| Teaching | 1 | 2021 | 195 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1810 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2003 | 713 | 0.040 |
Why?
|
| Quality Control | 1 | 1999 | 118 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2019 | 277 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 122 | 0.040 |
Why?
|
| Truth Disclosure | 1 | 1999 | 108 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 235 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2012 | 441 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1040 | 0.030 |
Why?
|
| Mental Processes | 1 | 1997 | 38 | 0.030 |
Why?
|
| United States Government Agencies | 1 | 2016 | 5 | 0.030 |
Why?
|
| Infant | 1 | 2011 | 13305 | 0.030 |
Why?
|
| Performance Anxiety | 1 | 2015 | 1 | 0.030 |
Why?
|
| Nigeria | 1 | 2015 | 69 | 0.030 |
Why?
|
| Office Visits | 1 | 2016 | 81 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 1996 | 93 | 0.030 |
Why?
|
| alpha-Fetoproteins | 1 | 2016 | 139 | 0.030 |
Why?
|
| Parents | 1 | 2022 | 1109 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2016 | 140 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1217 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 1996 | 169 | 0.030 |
Why?
|
| Counseling | 1 | 1996 | 237 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2016 | 392 | 0.020 |
Why?
|
| Awareness | 1 | 2013 | 81 | 0.020 |
Why?
|
| Nursing Records | 1 | 2011 | 5 | 0.020 |
Why?
|
| Cost Savings | 1 | 2012 | 78 | 0.020 |
Why?
|
| Decision Making | 1 | 1997 | 683 | 0.020 |
Why?
|
| Patient Care | 1 | 2011 | 99 | 0.020 |
Why?
|
| Heart Failure | 1 | 2003 | 2307 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1306 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2012 | 400 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2011 | 411 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 773 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 517 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 570 | 0.020 |
Why?
|
| Telefacsimile | 1 | 2006 | 1 | 0.020 |
Why?
|
| Systems Integration | 1 | 2006 | 24 | 0.020 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2006 | 47 | 0.020 |
Why?
|
| Critical Care | 1 | 2011 | 680 | 0.010 |
Why?
|
| Home Care Agencies | 1 | 2003 | 1 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 6279 | 0.010 |
Why?
|